Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice

Journal of Neurochemistry

Volumn 114, Issue 1, 2010, Pages 259-270

  Koda, Ken ^a   Ago, Yukio ^a   Cong, Yana ^a   Kita, Yuki ^a   Takuma, Kazuhiro ^a   Matsuda, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Atomoxetine; Dopamine; Methylphenidate; Mice; Prefrontal cortex; Striatum

Indexed keywords

ATOMOXETINE; DOPAMINE; METHYLPHENIDATE; NORADRENALIN; PROTEIN C FOS; SEROTONIN;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR SPACE; LOCOMOTION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN BRAIN LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN BRAIN LEVEL;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BIOGENIC MONOAMINES; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR SPACE; MALE; METHYLPHENIDATE; MICE; MICE, INBRED ICR; MICRODIALYSIS; MOTOR ACTIVITY; NEURONS; NOREPINEPHRINE; PREFRONTAL CORTEX; PROPYLAMINES; PROTO-ONCOGENE PROTEINS C-FOS; SEROTONIN;

MUS; RATTUS;

EID: 77953299678     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06750.x     Document Type: Article

References (54)

1. 1A receptor-mediated dopamine release in vivo in the frontal cortex of mice. J. Neurochem. 83, 353 359.
2. 1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 51, 914 922.
3. Ago Y., Nakamura S., Kajita N., Uda M., Hashimoto H., Baba A. Matsuda T. (2007) Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice. Synapse 61, 757 763. (Pubitemid 47122748)
4. Ago Y., Arikawa S., Yata M., Yano K., Abe M., Takuma K. Matsuda T. (2009) Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity. Synapse 63, 7 14.
5. Amini B., Yang P. B., Swann A. C. Dafny N. (2004) Differential locomotor responses in male rats from three strains to acute methylphenidate. Int. J. Neurosci. 114, 1063 1084.
6. Arnsten A. F. Li B. M. (2005) Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol. Psychiatry 57, 1377 1384.
7. Balcioglu A., Ren J. Q., McCarthy D., Spencer T. J., Biederman J. Bhide P. G. (2009) Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice. Neuropharmacology 57, 687 693.
8. Berridge C. W., Devilbiss D. M., Andrzejewski M. E., Arnsten A. F., Kelley A. E., Schmeichel B., Hamilton C. Spencer R. C. (2006) Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry 60, 1111 1120.
9. Biederman J. (2003) Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. J. Clin. Psychiatry 64 (Suppl. 11 3 8.
10. Bymaster F. P., Katner J. S., Nelson D. L., Hemrick-Luecke S. K., Threlkeld P. G., Heiligenstein J. H., Morin S. M., Gehlert D. R. Perry K. W. (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27, 699 711.
11. Camarero J., Sanchez V., O'Shea E., Green A. R. Colado M. I. (2002) Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum. J. Neurochem. 81, 961 972.
12. Carboni E., Tanda G. L., Frau R. Di Chiara G. (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55, 1067 1070.
13. Easton N., Steward C., Marshall F., Fone K. Marsden C. (2007) Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology 52, 405 414.
14. Franklin K. B. J. Paxinos G 1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, Inc
15. 2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J. Neurosci. 22, 8771 8777.
16. 3H]-tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites. Neurosci. Lett. 157, 203 206.
17. 3H]nisoxetine binding in rat brain. J. Neurochem. 64, 2792 2800.
18. Gehlert D. R., Schober D. A., Hemrick-Luecke S. K., Krushinski J., Howbert J. J., Robertson D. W., Fuller R. W. Wong D. T. (1995b) Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain. Neurochem. Int. 26, 47 52.
19. Gibson A. P., Bettinger T. L., Patel N. C. Crismon M. L. (2006) Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Ann. Pharmacother. 40, 1134 1142.
20. 2-autoreceptors. J. Neurosci. Methods 140, 141 152.
21. Grenhoff J. Svensson T. H. (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur. J. Pharmacol. 233, 79 84.
22. Hechtman L. Greenfield B. (2003) Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Paediatr. Drugs 5, 787 794.
23. Hernández L. F., Segovia G. Mora F. (2008) Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat. Neurochem. Int. 52, 457 469.
24. 2-adrenoceptors in the prefrontal cortex. Br. J. Pharmacol. 132, 183 188.
25. Jackson D. M., Mohell N., Georgiev J., Bengtsson A., Larsson L. G., Magnusson O. Ross S. B. (1995) Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 146 155.
26. Kitaichi Y., Inoue T., Izumi T., Nakagawa S., Kato A. Koyama T. (2005) Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats. Eur. J. Pharmacol. 520, 37 42. (Pubitemid 41375809)
27. Kollins S. H., English J., Robinson R., Hallyburton M. Chrisman A. K. (2009) Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) 204, 73 83.
28. van der Kooij M. A. Glennon J. C. (2007) Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 31, 597 618.
29. Kuczenski R. Segal D. S. (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem. 68, 2032 2037. (Pubitemid 27176139)
30. Kuczenski R. Segal D. S. (2002) Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J. Neurosci. 22, 7264 7271.
31. Linnèr L., Endersz H., Öhman D., Bengtsson F., Schalling M. Svensson T. (2001) Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J. Pharmacol. Exp. Ther. 297, 540 546.
32. 1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. J. Neurochem. 76, 865 871.
33. Mattiuz E. L., Ponsler G. D., Barbuch R. J. et al. (2003) Disposition and metabolic fate of atomoxetine hydrochloride: pharmacokinetics, metabolism, and excretion in the Fischer 344 rat and beagle dog. Drug Metab. Dispos. 31, 88 97.
34. Penner M. R., McFadyen M. P., Pinaud R., Carrey N., Robertson H. A. Brown R. E. (2002) Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration. Brain Res. Dev. Brain Res. 135, 71 77.
35. Peterson K., McDonagh M. S. Fu R. (2008) Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis. Psychopharmacology (Berl) 197, 1 11.
36. Sacchetti G., Bernini M., Bianchetti A., Parini S., Invernizzi R. W. Samanin R. (1999) Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain. Br. J. Pharmacol. 128, 1332 1338.
37. Schroeter S., Apparsundaram S., Wiley R. G., Miner L. H., Sesack S. R. Blakely R. D. (2000) Immunolocalization of the cocaine- and antidepressant- sensitive l-norepinephrine transporter. J. Comp. Neurol. 420, 211 232.
38. Seo D. O., Shin C. Y., Lee C. J., Dailey J. W., Reith M. E., Jobe P. C. Ko K. H. (1999) Effect of alterations in extracellular norepinephrine on adrenoceptors: a microdialysis study in freely moving rats. Eur. J. Pharmacol. 365, 39 46.
39. Sesack S. R., Hawrylak V. A., Matus C., Guido M. A. Levey A. I. (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 18, 2697 2708.
40. Shi W. X., Pun C. L., Zhang X. X., Jones M. D. Bunney B. S. (2000) Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors. J. Neurosci. 20, 3504 3511.
41. 3H]GBR 12935 as markers of dopamine innervation density in brain. Synapse 25, 163 175.
42. Tanaka K., Shintani N., Hashimoto H. et al. (2006) Psychostimulant- induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J. Neurosci. 26, 5091 5097.
43. Tanda G., Frau R. Di Chiara G. (1996) Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex. Psychopharmacology (Berl) 127, 83 87.
44. Tanda G., Pontieri F. E., Frau R. Di Chiara G. (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci. 9, 2077 2085.
45. Tatsumi M., Groshan K., Blakely R. D. Richelson E. (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur. J. Pharmacol. 340, 249 258.
46. Vitiello B. (2001) Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 11, 25 34.
47. Volkow N. D. Swanson J. M. (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psychiatry 160, 1909 1918.
48. Weikop P., Yoshitake T. Kehr J. (2007) Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain. Eur. Neuropsychopharmacol. 17, 658 671.
49. Wilens T. E., Faraone S. V., Biederman J. Gunawardene S. (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111, 179 185.
50. Yamamoto B. K. Novotney S. (1998) Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem. 71, 274 280.
51. Yan T. C., Hunt S. P. Stanford S. C. (2009) Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder. Neuropharmacology 57, 627 635.
52. Yang P. B., Swann A. C. Dafny N. (2006) Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumbens, prefrontal cortex, and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Res. 1073-1074, 164 174.
53. 1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci. 17, 8528 8535.
54. Zhuang X., Oosting R. S., Jones S. R., Gainetdinov R. R., Miller G. W., Caron M. G. Hen R. (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl Acad. Sci. USA 98, 1982 1987.